Bovine leukemia virus (BLV) is an exogenous retrovirus and associated with enzootic bovine leukosis (EBL)4 which often includes persistent lymphocytosis and development of B-cell lymphosarcoma/leukemia after a long latent period. Natural cases of malignant lymphomas are rare in sheep. Under experimental conditions, however, sheep are easily infected with BLV7 and develop B-cell lymphosarcoma/leukemia at a higher frequency and within a shorter period (1 to 3 years) than cattle. Sheep also show serologic and pathologic responses to BLV similar to those in The lymphoid systems of sheep and cattle contain a large number of the CD4-CD8-"double-negative" T lymphocyte s~b p o p u l a t i o n~-~ in striking contrast to the lymphoid systems of human and mouse. These double-negative lymphocytes are known to express the y6 chains of T cell receptor (TCR)2.3 as well as a surface molecule termed T19.6 In spleen and lymph nodes, y6 T cells are localized in regions of cellular traffic5 and they exhibit cytotoxic activity against allogenic cells. In order to elucidate the role of y6 T cells in BLVinfected sheep, we examined, by flow cytometry, the population of y6 T cells in the peripheral blood mononuclear cells (PBMC). The distribution of these cells in the superficial cervical lymph nodes of BLV-infected sheep was examined by immunohistology using the monoclonal antibody (MoAb) against the y6 TCR.
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Fourteen 6-month-old sheep (Suffolk, Corridale and crossbreed), negative for BLV-specific antibodies, were hypodermally inoculated with 1.0 ml of blood from BLV-infected cattle. BLV-infected sheep were classified according to clinical and hematological observations, and the host genome integration pattern of the BLV provirus in PBMC or lymph nodes. For histological observation, lymph node sections were obtained from two BLV-infected but healthy sheep and five sheep with lymphosarcoma. For flow cytometry, blood samples were obtained from seven BLV-infected but healthy sheep and two sheep with lymphosarcoma. Seven sheep (Corridale and Suffolk) were kept for 3 to 4 years without inoculation, two were sacrificed as controls for immunohistological observation, and five were used for flow cytometry. Immunodiffusion test was performed for detection of antibodies against BLV, using the BLV env glycoprotein gp60 and the gag protein p24.
Monoclonal antibodies 86D (anti+ TCR) and 197 (anti-T I 9 antigen) were kindly provided by Dr. c . R. Mackay (Basel Institute for Immunology, Basel, Switzerland). PIg45A
MoAb (anti-IgM) was purchased from Veterinary Medical Research and Development Inc. (Pullman, WA).
Pieces approximately 1 cm thick of each superficial cervical lymph node were frozen rapidly by immersion in liquid nitrogen and preserved at -80 C. Cryosections were stained by the avidin biotin peroxidase complex technique in accordance with the manufacturer's instructions (Vector Laboratories, Burlingame, CA) with either 86D MoAb or normal mouse serum as the negative control. Each section was observed by microscope, using an apchromatic 40 x objective and widefield 10 x ocular lens (Olympus BHS, Tokyo). The number of the 86D MoAb-positive cells was counted inside photographic field (1 80 x 120 pm square). Five different fields were randomly examined in each section. The percentage of 86D MoAb-positive cells out oftotal cells analyzed was determined. A mean value and the standard deviation were calculated. Differences in the number of positive cells of lymphocytes among the three groups of sheep were evaluated by the Mann-Whitney U-test for differences between frequency distributions.
PBMC from BLV-infected sheep were examined by flow cytometry for reactivities with 86D, 197 and pIg-45A MoAbs ( Table 1) . Increases in both the proportion and the actual number of surface immunoglobulin M (sIgM)-bearing cells were observed in PBMC of all BLV-infected sheep. The proportion of sIgM-positive cells in PBMC from BLV-free normal sheep was approximately 23.3%, while that in the BLVinfected but healthy sheep was 55.6%. The proportion was much higher in the case of PBMC from sheep with lymphosarcoma (88.0% and 99.7%). In contrast, the proportion and the actual number of y6 T cells and those of T19-bearing cells in most BLV-infected but healthy sheep were almost the same as those in BLV-free normal sheep. Although two sheep with lymphosarcoma had considerably lower proportions of y6 T cells and T 19-bearing cells than BLV-free normal sheep, the actual numbers of these cells were not significantly different from those in BLV-free normal sheep (P < 0.05).
In order to determine the distribution of76 T cells in lymph nodes, we stained cryosections of superficial cervical lymph node with the 86D MoAb ( Figs. 1-4 ). In two BLV-free normal sheep, y6 T cells were prominent in the marginal sinus of the cortex and were scattered in the perifollicular area in the cortex, but were not in the follicles (Fig. 1) . The proportions of y6 T cells determined in the defined area of the stained sections from BLV-free normal sheep were on average 14 ? 6.9% and 6.2 ? 3.0% in the cortex and the medulla, respectively. In two BLV-infected but healthy sheep, which had hypertrophic follicles with germinal centers, the y6 T cells were localized in the proximity of the marginal sinus of the cortex, but not in follicles (Fig. 2) . Whereas, in these cases, the proportions of y6 T cells in the medulla were almost the same as those in BLV-free normal sheep (5.3 -t 1.5%), those in the cortex were reduced (5.4% and 0.4%) with enlargement of follicles, compared with BLV-free normal sheep (P < 0.05). In five sheep with lymphosarcoma, very few cells that reacted with the 86D MoAb (1.7 f 1.3%) were scattered over the entire tumorous lymph node which had lost its original structure because of the proliferation of neoplastic cells (Fig. 3 ). In only one of these sheep, however, a few areas where the yb T cells had clustered were observed in sections of the tumorous lymph node (Fig. 4) .
Flow-cytometric analysis clearly showed that the actual number (but not the proportion) of yb T cells were similar in the PBMC from BLV-infected but healthy sheep and sheep with lymphosarcoma to those from BLV-free normal sheep. The immunohistologic study using the anti-yb TCR MoAb indicated 1) the proportion of yb T cells in the cortex of the superficial cervical lymph node decreased in the BLV-infected but healthy sheep because of enlarged hypertrophic follicles where the y6 T cells did not exist, 2) the yb T cells were sparsely scattered throughout the tumorous lymph node from sheep with lymphosarcoma, and 3) local areas of accumulation of 7 6 T cells were observed in sections of tu-
